Bionomics Ltd (External organisation)

  • Flynn, B. L. (Inventor)
  • Jonathan Baell (Inventor)
  • Andrew J. Harvey (Inventor)
  • Jason Hugh Chaplin (Inventor)
  • Dharam Paul (Inventor)
  • Jorgen Mould (Inventor)

Activity: Industry, Government and Philanthropy Engagement and PartnershipsPatentsPatent


Novel benzofuran potassium channel blockers and uses thereof

Abstract: The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.

WO2008040057A1 - WIPO (PCT)
Application PCT/AU2007/001475 events
2006-10-04 Priority to US84948806P
2006-10-04 Priority to US60/849,488
2007-10-04 Application filed by Bionomics Limited
2008-04-10 Publication of WO2008040057A1

Related patent documents
US20100087430 AU2007304880 NZ575685
Held atBionomics Ltd, Australia, South Australia
Degree of RecognitionInternational